SCHEMBL9928556

SCHEMBL9928556

COc1ccc(-c2cn(-c3nc4c([nH]3)c(=O)n(C)c(=O)n4C)nn2)cc1

nearest known ligand 0.61

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 3/20 0.61
KDM4E B2RXH2 2/20 0.48
ALDH1A1 P00352 1/20 0.48
GAA P10253 1/20 0.48
MAPT P10636 1/20 0.48
PKM P14618 1/20 0.48
KDM4C Q9H3R0 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
ADORA2A P29274 3/20 0.45
EGFR P00533 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9928557 0.88 ADORA2B (0.49) ADORA2BKDM4ECYP1A2CYP3A4ADORA2A
SCHEMBL9904126 0.87 DCTPP1 (0.56) ADORA2BKDM4EALDH1A1CYP1A2ADORA2A
SCHEMBL9904014 0.84 PTGS2 (0.45) ADORA2BKDM4ECYP1A2ADORA2A
SCHEMBL9904107 0.84 ADORA2B (0.46) ADORA2BKDM4EALDH1A1CYP1A2ADORA2A
SCHEMBL9904113 0.81 KDM4E (0.49) ADORA2BKDM4EALDH1A1GAACYP1A2
SCHEMBL9904105 0.81 ADORA2B (0.65) ADORA2BKDM4EALDH1A1GAAMAPT
SCHEMBL9943454 0.81 ALDH1A1 (0.64) ADORA2BKDM4EALDH1A1GAACYP1A2
SCHEMBL9928558 0.81 ADORA2A (0.43) ADORA2BKDM4EGAACYP1A2ADORA2A
SCHEMBL9904312 0.79 ADORA2B (0.48) ADORA2BKDM4EALDH1A1MAPTCYP1A2
SCHEMBL9904008 0.79 MAPT (0.57) ADORA2BKDM4EALDH1A1MAPTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2465859-A1 8-Triazolylxanthine derivatives, processes for their production and their use as adenosine receptor antagonists Life & Brain GmbH (DE) 2012-06-20 EP disclosed
WO-2012076974-A1 8-TRIAZOLYLXANTHINE DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS ADENOSINE RECEPTOR ANTAGONISTS LIFE & BRAIN GMBH (DE) 2012-06-14 WO disclosed